Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.9B | 13.7B | 13.6B | 15.1B |
Cost of revenue | 10.3B | 10.2B | 10.5B | 11.7B |
Gross profit | 3.6B | 3.4B | 3.1B | 3.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.2B | 1.2B | 1.1B | 1.1B |
Operating income | 1.6B | 1.5B | 1.2B | 1.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 6.1M | 5.2M | 5.7M | 5.5M |
Other income expense | — | — | — | — |
Pretax income | 2.1B | 1.8B | 1.6B | 1.8B |
Tax provision | 542.5M | 431.6M | 409.6M | 420.7M |
Net income | 1.6B | 1.4B | 1.2B | 1.4B |
Basic EPS | — | 9.9 | 8.3 | 9.4 |
Diluted EPS | — | 9.9 | 8.3 | 9.4 |
Basic average shares | — | 136.3M | 136.3M | 136.2M |
Diluted average shares | — | 136.3M | 136.3M | 136.2M |
EBITDA | 2.3B | 2.0B | 1.8B | 1.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | -54.2M | -56.0M | -78.2M | -93.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |